Changes in immune profile affect disease progression in hepatocellular carcinoma

Area of Science:

• Immunology
• Oncology
• Hepatology

Background:

• Hepatocellular carcinoma (HCC) development is closely linked to immune responses.
• Specific lymphocyte subsets play critical roles in the progression and outcome of solid tumors like HCC.

Purpose of the Study:

• To investigate the relationship between immune system alterations and disease progression in HCC patients.
• To compare immune cell profiles in HCC patients versus healthy individuals.

Main Methods:

• Peripheral blood mononuclear cells were isolated from 30 HCC patients and 30 healthy controls.
• Flow cytometry was used to determine the percentages of various immune cell populations after antibody staining.

Main Results:

• HCC patients exhibited significantly lower CD4+ T cells, Tbet+IFNγ+ cells, and GATA+IL-4+ cells compared to healthy individuals.
• A significant increase in Foxp3+CD127low regulatory T cells (Tregs) was observed in HCC patients.
• Th1, Th2, and Th17 cell frequencies were lower in HCC patients, while Treg percentages were higher, correlating with TNM stages.

Conclusions:

• Immune system dysregulation, characterized by reduced effector T cells and increased Tregs, is associated with HCC progression.
• Further research is necessary to elucidate the precise roles of specific immune cells in HCC pathogenesis and their impact on disease outcomes.